Substance / Medication

Avibactam

Overview

Active Ingredient
avibactam
RxNorm CUI
1603834
Labeler: AbbVie Inc.Updated: 2025-02-07T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

[see Warnings and Precautions ( 5.1 )] EMBLAVEO is contraindicated in patients with known hypersensitivity to the components of EMBLAVEO (aztreonam and avibactam).

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy of Ceftazidime-avibactam in treating Gram-negative infections: a systematic review and meta-analysis.
Khoshdel Nahal, Noursalehigarakani Melina, Seghatoleslami Zahra Sadat et al. · Eur J Clin Microbiol Infect Dis · 2025
PMID: 39841366Meta-AnalysisFull text (PMC)
Global trends of ceftazidime-avibactam resistance in gram-negative bacteria: systematic review and meta-analysis.
Wang Yang, Sholeh Mohammad, Yang LunDi et al. · Antimicrob Resist Infect Control · 2025
PMID: 39934901Meta-AnalysisFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Avibactam (substance)
SNOMED CT
715180004
UMLS CUI
C3489748
RxNorm CUI
1603834
Labeler
AbbVie Inc.

Clinical Data

This intervention maps to 5 entities in the Healos knowledge graph.

5
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.